Chemotherapeutisches Forschungsinstitut Georg-speyer-Haus

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chemotherapeutisches Forschungsinstitut Georg-speyer-Haus.The latest application filed is for "periostin compounds for the treatment of haematological complications".

Company Profile

4.11.13

Chemotherapeutisches Forschungsinstitut Georg-speyer-Haus - Frankfurt am Main DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Periostin Compounds For The Treatment Of Haematological Complications App 20210261638 - Krause; Daniela S. ; et al.	2021-08-26
Methods And Compounds For Improved Immune Cell Therapy App 20210128615 - Wels; Winfried ; et al.	2021-05-06
Chimeric antigen receptors with an optimized hinge region Grant 10,556,969 - Schonfeld , et al. Feb	2020-02-11
CAR-expressing NK-92 cells as cell therapeutic agents Grant 10,550,197 - Wels , et al. Fe	2020-02-04
Fibronectin Or Ilk Inhibitors For Use In The Treatment Of Leukemia App 20190374618 - Krause; Daniela ; et al.	2019-12-12
Interleukin 15 as selectable marker for gene transfer in lymphocytes Grant 10,351,612 - Schonfeld , et al. July 16, 2	2019-07-16
Car-expressing Nk-92 Cells As Cell Therapeutic Agents App 20180282427 - Wels; Winfried ; et al.	2018-10-04
CAR-expressing NK-92 cells as cell therapeutic agents Grant 9,920,132 - Wels , et al. March 20, 2	2018-03-20
Chimeric Antigen Receptors With An Optimized Hinge Region App 20180022828 - SCHONFELD; Kurt ; et al.	2018-01-25
Chimeric antigen receptors with an optimized hinge region Grant 9,815,908 - Schonfeld , et al. November 14, 2	2017-11-14
Car-expressing Nk-92 Cells As Cell Therapeutic Agents App 20170283507 - Wels; Winfried ; et al.	2017-10-05
Car-expressing Nk-92 Cells As Cell Therapeutic Agents App 20170129967 - Wels; Winfried ; et al.	2017-05-11
Interleukin 15 as Selectable Marker for Gene Transfer in Lymphocytes App 20170044227 - SCHONFELD; Kurt ; et al.	2017-02-16
Chimeric Antigen Receptors With An Optimized Hinge Region App 20160046729 - SCHONFELD; Kurt ; et al.	2016-02-18
Chimeric antigen receptors with an optimized hinge region Grant 9,212,229 - Schonfeld , et al. December 15, 2	2015-12-15
Chimeric Antigen Receptors With An Optimized Hinge Region App 20130280285 - Schonfeld; Kurt ; et al.	2013-10-24
Interleukin 15 as Selectable Marker for Gene Transfer in Lymphocytes App 20130280221 - Schonfeld; Kurt ; et al.	2013-10-24
Optimized DNA sequence of an antibody to improve quality and yield of bacterially expressed antibody fusion proteins Grant 8,530,637 - Wels , et al. September 10, 2	2013-09-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.